Recommendation for standardized surgical management of primary adrenocortical carcinoma

Surgery (United States)

Volumn 152, Issue 1, 2012, Pages 123-132

  Gaujoux, Sébastien ^a,b,c   Brennan, Murray F ^d  

^a Assistance Publique Hôpitaux de Paris ^*  (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c INSTITUT COCHIN   (France)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENAL CORTEX CARCINOMA; ADRENAL GLAND; CANCER INVASION; CANCER PROGNOSIS; CANCER SURGERY; CANCER SURVIVAL; CELIAC ARTERY; DISEASE SEVERITY; HUMAN; KIDNEY; LYMPH NODE; LYMPH NODE METASTASIS; LYMPHADENECTOMY; PARAAORTIC LYMPH NODE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; STANDARDIZATION; SYSTEMATIC REVIEW;

ADRENAL CORTEX NEOPLASMS; ADRENALECTOMY; ADRENOCORTICAL CARCINOMA; DISEASE MANAGEMENT; HUMANS; LYMPH NODE EXCISION; NEPHRECTOMY;

EID: 84862857562     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2011.09.030     Document Type: Review

References (85)

1. Dackiw AP, Lee JE, Gagel RF, Evans DB. Adrenal cortical carcinoma. World J Surg 2001;25:914-26.
2. Kebebew E, Reiff E, Duh QY, Clark OH, McMillan A. Extent of disease at presentation and outcome for adrenocortical carcinoma: have we made progress? World J Surg 2006;30: 872-8.
3. Hutter AM Jr, Kayhoe DE. Adrenal cortical carcinoma. Clinical features of 138 patients. Am J Med 1966;41:572-80.
4. Pommier RF, Brennan MF. An eleven-year experience with adrenocortical carcinoma. Surgery 1992;112:963-70.
5. Stojadinovic A, Ghossein RA, Hoos A, Nissan A, Marshall D, Dudas M, et al. Adrenocortical carcinoma: clinical, morphologic, and molecular characterization. J Clin Oncol 2002;20: 941-50.
6. Wajchenberg BL, Albergaria Pereira MA, Medonca BB, Latronico AC, Campos Carneiro P, Alves VA, et al. Adrenocortical carcinoma: clinical and laboratory observations. Cancer 2000;88:711-36.
7. Allolio B, Fassnacht M. Clinical review: adrenocortical carcinoma: clinical update. J Clin Endocrinol Metab 2006;91: 2027-37.
8. Fassnacht M, Allolio B. Clinical management of adrenocortical carcinoma. Best Pract Res Clin Endocrinol Metab 2009; 23:273-89.
9. Schulick RD, Brennan MF. Long-term survival after complete resection and repeat resection in patients with adrenocortical carcinoma. Ann Surg Oncol 1999;6: 719-26.
10. Bellantone R, Ferrante A, Boscherini M, Lombardi CP, Crucitti P, Crucitti F, et al. Role of reoperation in recurrence of adrenal cortical carcinoma: results from 188 cases collected in the Italian National Registry for Adrenal Cortical Carcinoma. Surgery 1997;122:1212-8.
11. Icard P, Goudet P, Charpenay C, Andreassian B, Carnaille B, Chapuis Y, et al. Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons study group. World J Surg 2001; 25:891-7.
12. Fassnacht M, Hahner S, Polat B, Koschker AC, Kenn W, Flentje M, et al. Efficacy of adjuvant radiotherapy of the tumor bed on local recurrence of adrenocortical carcinoma. J Clin Endocrinol Metab 2006;91:4501-4.
13. Polat B, Fassnacht M, Pfreundner L, Guckenberger M, Bratengeier K, Johanssen S, et al. Radiotherapy in adrenocortical carcinoma. Cancer 2009;115:2816-23.
14. Bilimoria KY, Shen WT, Elaraj D, Bentrem DJ, Winchester DJ, Kebebew E, et al. Adrenocortical carcinoma in the United States: treatment utilization and prognostic factors. Cancer 2008;113:3130-6.
15. Fassnacht M, Johanssen S, Quinkler M, Bucsky P, Willenberg HS, Beuschlein F, et al. Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma: proposal for a Revised TNM Classification. Cancer 2009;115:243-50.
16. Lughezzani G, Sun M, Perrotte P, Jeldres C, Alasker A, Isbarn H, et al. The European Network for the Study of Adrenal Tumors staging system is prognostically superior to the international union against cancer-staging system: A North American validation. Eur J Cancer 2010;46:713-9.
17. Icard P, Chapuis Y, Andreassian B, Bernard A, Proye C. Adrenocortical carcinoma in surgically treated patients: a retrospective study on 156 cases by the French Association of Endocrine Surgery. Surgery 1992;112:972-9.
18. Icard P, Louvel A, Chapuis Y. Survival rates and prognostic factors in adrenocortical carcinoma. World J Surg 1992;16: 753-8.
19. Mascagni P. Vasorum lymphaticorumcorporis humani. Historia et Ichonographia Sienne 1787.
20. Cruikshank M. Anatomie des vaisseaux absorbants du corps humain. Paris: Froullé; 1787:309-10.
21. Sappey PC. Anatomie, physiologie, pathologie des vaisseaux lymphatiques. Paris: Adrien Delahaye; 1874:122-3.
22. Grégoire R. Vaisseaux et ganglions lymphatiques de la capsule surrénale. Bull Soc Anat 1904;79:820-3.
23. Rouvière H. Anatomie des lymphatiques de l'homme. Paris: Masson; 1932:364-7.
24. Merklin RJ. Suprarenal gland lymphatic drainage. Am J Anat 1966;119:359-74.
25. Kumita K. Uber die parenchymatôsen lymphbahnen der nebenniere. Arch f Anat Physiol 1909:321-6.
26. Kumita K. Uber die lymphgefässe der nieren- und nebennierenkapsel. Arch f Anat Physiol 1909:49-58.
27. Hidden G, Caplan I. Le drainage lymphatique des surrénales: Anatomie Médico-chirurgicale Paris-Buenos-Aires: Laboratoire d'anatomie de la Faculte de Medecine de Paris, 1984.
28. Hureau J, Hidden G, Ta Thanh Minh A. Vascularisation des glandes surrénales. Anatomia Clinica 1979;2:127-46.
29. Wenzel J. Normal Anatomies des Lymphgefässystems: Nebenniere. Handbuch der allgemeinen Pathologie. Berlin: Springer; 1972:112.
30. Avisse C, Marcus C, Patey M, Ladam-Marcus V, Delattre JF, Flament JB. Surgical anatomy and embryology of the adrenal glands. Surg Clin North Am 2000;80:403-15.
31. Bartels P. Das lymphgefässysteme. Iena, Germany: G. Fischer; 1909:233-4.
32. Tokiwa K, Nakamura K, Ogita S, Iwai N, Hagiwara A, Takahashi T. Lymphatic drainage of adrenal neuroblastoma. J Pediatr Surg 1993;28:927-9.
33. Contador MP, Johnston S, Smith EI, Shuster JJ, Hayes FA, Castleberry RP. Lymph node sampling in localized neuroblastoma: a Pediatric Oncology Group study. J Pediatr Surg 1999;34:967-74.
34. Grubbs EG, Callender GG, Xing Y, Perrier ND, Evans DB, Phan AT, et al. Recurrence of adrenal cortical carcinoma following resection: surgery alone can achieve results equal to surgery plus mitotane. Ann Surg Oncol 2010;17:263-70.
35. Harrison LE, Gaudin PB, Brennan MF. Pathologic features of prognostic significance for adrenocortical carcinoma after curative resection. Arch Surg 1999;134:181-5.
36. Crucitti F, Bellantone R, Ferrante A, Boscherini M, Crucitti P. The Italian Registry for Adrenal Cortical Carcinoma: analysis of a multiinstitutional series of 129 patients. The ACC Italian Registry Study Group. Surgery 1996;119:161-70.
37. Macfarlane DA. Cancer of the adrenal cortex; the natural history, prognosis and treatment in a study of fifty-five cases. Ann R Coll Surg Engl 1958;23:155-86.
38. Terzolo M, Angeli A, Fassnacht M, Daffara F, Tauchmanova L, Conton PA, et al. Adjuvant mitotane treatment for adrenocortical carcinoma. N Engl J Med 2007;356:2372-80.
39. Soreide JA, Brabrand K, Thoresen SO. Adrenal cortical carcinoma in Norway, 1970-1984. World J Surg 1992;16: 663-7.
40. King DR, Lack EE. Adrenal cortical carcinoma: a clinical and pathologic study of 49 cases. Cancer 1979;44: 239-44.
41. Sullivan M, Boileau M, Hodges CV. Adrenal cortical carcinoma. J Urol 1978;120:660-5.
42. Lee JE, Berger DH, el-Naggar AK, Hickey RC, Vassilopoulou- Sellin R, Gagel RF, et al. Surgical management, DNA content, and patient survival in adrenal cortical carcinoma. Surgery 1995;118:1090-8.
43. Kendrick ML, Lloyd R, Erickson L, Farley DR, Grant CS, Thompson GB, et al. Adrenocortical carcinoma: surgical progress or status quo? Arch Surg 2001;136:543-9.
44. Mitchell GA. The renal fascia. Br J Surg 1950;37:257-66.
45. Thornbury J. Perirenal anatomy: normal and abnormal. Radiol Clin North Am 1979;17:321-31.
46. Congdon E, Edson J. The cone of renal fascia in the adult white man. Anat Rec 1941;80:289-313.
47. Lim JH, Yoon Y, Lee SW, Ko YT, Choi WS, Lee DH, et al. Superior aspect of the perirenal space: anatomy and pathological correlation. Clin Radiol 1988;39:368-72.
48. Lim JH, Auh YH. Anatomic relation between the bare area of the liver and the right perirenal space. AJR Am J Roentgenol 1994;162:733-4.
49. Lim JH, Auh YH, Suh SJ, Kim KW. Right perirenal space. Computed tomography evidence of communication between the bare area of the liver. Clin Imaging 1990;14:239-44.
50. Lim JH, Kim B, Auh YH. Continuation of gas from the right perirenal space into the bare area of the liver. J Comput Assist Tomogr 1997;21:667-70.
51. O'Malley RL, Godoy G, Kanofsky JA, Taneja SS. The necessity of adrenalectomy at the time of radical nephrectomy: a systematic review. J Urol 2009;181:2009-17.
52. Lane BR, Tiong HY, Campbell SC, Fergany AF, Weight CJ, Larson BT, et al. Management of the adrenal gland during partial nephrectomy. J Urol 2009;181:2430-6.
53. Causeret S, Monneuse O, Mabrut JY, Berger N, Peix JL. Adrenocortical carcinoma: prognostic factors for local recurrence and indications for reoperation. A report on a series of 22 patients [in French]. Ann Chir 2002;127: 370-7.
54. Chiche L, Dousset B, Kieffer E, Chapuis Y. Adrenocortical carcinoma extending into the inferior vena cava: presentation of a 15-patient series and review of the literature. Surgery 2006;139:15-27.
55. Johnstone FR. The suprarenal veins. Am J Surg 1957;94: 615-20.
56. Turbendian HK, Strong VE, Hsu M, Ghossein RA, Fahey TJ 3rd. Adrenocortical carcinoma: the influence of large vessel extension. Surgery 2010;148:1057-64.
57. Mehta T, Wade RG, Clarke JM. Is it safe to ligate the left renal vein during open abdominal aortic aneurysm repair? Ann Vasc Surg 2010;24:758-61.
58. Ohwada S, Izumi M, Tanahashi Y, Kawate S, Hamada K, Tsutsumi H, et al. Combined liver and inferior vena cava resection for adrenocortical carcinoma. Surg Today 2007;37: 291-7.
59. Hedican SP, Marshall FF. Adrenocortical carcinoma with intracaval extension. J Urol 1997;158:2056-61.
60. Siegelbaum MH, Moulsdale JE, Murphy JB, McDonald GR. Use of magnetic resonance imaging scanning in adrenocortical carcinoma with vena caval involvement. Urology 1994; 43:869-73.
61. Figueroa AJ, Stein JP, Lieskovsky G, Skinner DG. Adrenal cortical carcinoma associated with venous tumour thrombus extension. Br J Urol 1997;80:397-400.
62. Martínez-Salamanca JI, Huang WC, Millán I, Bertini R, Bianco FJ, Carballido JA, et al. Prognostic impact of the 2009 UICC/AJCC TNM Staging System for Renal Cell Carcinoma with Venous Extension. Eur Urol 2011;59: 120-7.
63. MacFarlane JK, Ryall RD, Heald RJ. Mesorectal excision for rectal cancer. Lancet 1993;341:457-60.
64. Chen SL, Bilchik AJ. More extensive nodal dissection improves survival for stages I to III of colon cancer: a population-based study. Ann Surg 2006;244:602-10.
65. Le Voyer TE, Sigurdson ER, Hanlon AL, Mayer RJ, Macdonald JS, Catalano PJ, et al. Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol 2003; 21:2912-9.
66. Johnson PM, Porter GA, Ricciardi R, Baxter NN. Increasing negative lymph node count is independently associated with improved long-term survival in stage IIIB and IIIC colon cancer. J Clin Oncol 2006;24:3570-5.
67. Berger AC, Sigurdson ER, LeVoyer T, Hanlon A, Mayer RJ, Macdonald JS, et al. Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. J Clin Oncol 2005;23:8706-12.
68. Jaeck D. The significance of hepatic pedicle lymph nodes metastases in surgical management of colorectal liver metastases and of other liver malignancies. Ann Surg Oncol 2003; 10:1007-11.
69. Lee JH, Ryu KW, Kim YW, Bae JM. Staging laparoscopy in gastric cancer: a single port method. J Surg Oncol 2003; 84:50-2.
70. Doi R, Kami K, Ito D, Fujimoto K, Kawaguchi Y, Wada M, et al. Prognostic implication of para-aortic lymph node metastasis in resectable pancreatic cancer. World J Surg 2007; 31:147-54.
71. Yeo CJ, Cameron JL, Lillemoe KD, Sohn TA, Campbell KA, Sauter PK, et al. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality. Ann Surg 2002;236:355-66.
72. Sasako M, Sano T, Yamamoto S, Kurokawa Y, Nashimoto A, Kurita A, et al. D2 lymphadenectomy alone or with paraaortic nodal dissection for gastric cancer. N Engl J Med 2008;359:453-62.
73. Veytsman I, Nieman L, Fojo T. Management of endocrine manifestations and the use of mitotane as a chemotherapeutic agent for adrenocortical carcinoma. J Clin Oncol 2009;27:4619-29.
74. Schteingart DE, Doherty GM, Gauger PG, Giordano TJ, Hammer GD, Korobkin M, et al. Management of patients with adrenal cancer: recommendations of an international consensus conference. Endocr Relat Cancer 2005; 12:667-80.
75. Berruti A, Fassnacht M, Baudin E, Hammer G, Haak H, Leboulleux S, et al. Adjuvant therapy in patients with adrenocortical carcinoma: a position of an international panel. J Clin Oncol 2010;28:e401-2.
76. Brix D, Allolio B, Fenske W, Agha A, Dralle H, Jurowich C, et al. Laparoscopic versus open adrenalectomy for adrenocortical carcinoma: surgical and oncologic outcome in 152 patients. Eur Urol 2010;58:609-15.
77. Miller BS, Ammori JB, Gauger PG, Broome JT, Hammer GD, Doherty GM. Laparoscopic resection is inappropriate in patients with known or suspected adrenocortical carcinoma. World J Surg 2010;34:1380-5.
78. Porpiglia F, Fiori C, Daffara F, Zaggia B, Bollito E, Volante M, et al. Retrospective evaluation of the outcome of open versus laparoscopic adrenalectomy for stage I and II adrenocortical cancer. Eur Urol 2010;57:873-8.
79. Leboulleux S, Deandreis D, Al Ghuzlan A, Auperin A, Goere D, Dromain C, et al. Adrenocortical carcinoma: is the surgical approach a risk factor of peritoneal carcinomatosis? Eur J Endocrinol 2010;162:1147-53.
80. Gonzalez RJ, Shapiro S, Sarlis N, Vassilopoulou-Sellin R, Perrier ND, Evans DB, et al. Laparoscopic resection of adrenal cortical carcinoma: a cautionary note. Surgery 2005;138: 1078-85.
81. Brix D, Allolio B, Fenske W, Agha A, Dralle H, Jurowich C, et al. Laparoscopic versus open adrenalectomy for adrenocortical carcinoma: surgical and oncologic outcome in 152 patients. Eur Urol 2010;58:609-15.
82. Bonjer HJ, Hop WC, Nelson H, Sargent DJ, Lacy AM, Castells A, et al. Laparoscopically assisted vs open colectomy for colon cancer: a meta-analysis. Arch Surg 2007;142:298-303.
83. Gaujoux S, Bonnet S, Dousset B. Re: David Brix, Bruno Allolio, Wiebke Fenske, et al. Laparoscopic Versus Open Adrenalectomy for Adrenocortical Carcinoma: Surgical and Oncologic Outcome in 152 Patients. Eur Urol 2010;58: 609-15, e53.
84. Fassnacht M, Johanssen S, Fenske W, Weismann D, Agha A, Beuschlein F, et al. Improved survival in patients with stage II adrenocortical carcinoma followed up prospectively by specialized centers. J Clin Endocrinol Metab 2010;95: 4925-32.
85. Fong Y, Gonen M, Rubin D, Radzyner M, Brennan MF. Long-term survival is superior after resection for cancer in high-volume centers. Ann Surg 2005;242:540-4.